Solana Company Class A
As of Oct 22, 2026, Solana is in Stage 2, the uptrend phase, now in week 3 (since Oct 5, 2026). It closed at $2.26, 67.7% below its 52-week high and above its 200-day average, which is falling.
Solana Company operates as a listed digital asset treasury. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 45 in Asset Management · #1 of 215 in Financials
Is HSDT early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
HSDT among Asset Management126th of 140 by relative strength
All 140 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CYPH | Stage 2 · wk 7 | 99 | −17.5% |
| 2 | AMTD | Stage 2 · wk 1 | 99 | +4011.1% |
| 3 | MGLD | Stage 2 · wk 4 | 94 | +105.2% |
| 4 | AAMI | Stage 2 · wk 41 | 94 | +1.4% |
| 5 | ASST | Stage 2 · wk 7 | 92 | +0.1% |
| 6 | AMG | Stage 2 · wk 21 | 91 | +8.0% |
| 7 | WT | Stage 2 · wk 39 | 91 | −10.6% |
| 8 | VCTR | Stage 2 · wk 39 | 91 | +1.0% |
| …126 | HSDT | Stage 2 · wk 3 | 16 | −21.5% |
Solana: quick answers
What stage is Solana in?
As of Oct 22, 2026, Solana (HSDT) is in Stage 2, the uptrend phase. It entered Stage 2 on Oct 5, 2026 and is in week 3. What the four stages mean
Is Solana in an uptrend?
Yes. Solana is in a Stage 2 uptrend. It trades 6.1% above its 200-day average, which is falling.
How far is Solana from its 52-week high?
Solana closed at $2.26 on Oct 22, 2026, 67.7% below its 52-week high of $7.00. Its 52-week low is $1.27.
How has Solana performed over the past year?
As of Oct 22, 2026, Solana is down 66.2% over the past year and down 26.9% so far in 2026.
Which sector and industry is Solana in?
Solana is in the Asset Management industry, part of the Financials sector.
About this companyFinancials· Asset Management
Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications. It also focuses on neurological wellness. In addition, the company offers Portable Neuromodulation Stimulator, a non-implantable medical device, which delivers mild electrical stimulation to the surface of the tongue to provide treatment of gait deficit and chronic balance deficit. Solana Company is headquartered in Newtown, Pennsylvania.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.